09 May 2018

排三开奖结果走势图: Luye Pharma Group (listed in Hong Kong) and AstraZeneca enter US$546 million agreement for rights to Seroquel and Seroquel XR in the UK, China and other international markets

内蒙古快三专家预测 www.v6hfk.cn On 7th May, 2018, King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating to the sale and licence of the rights to Seroquel and Seroquel XR (Products) in the UK, China and other 49 international markets, including Brazil, Australia, Saudi Arabia, Mexico, South Korea, Thailand, Argentina, Malaysia and South Africa. The purchase price for the transferred and licensed assets is US$546 million and is payable in four instalments.

The transaction is expected to close by the end of half year 2018, subject to customary closing conditions. As part of the transaction, Luye Pharma group will enter into a supply agreement with AstraZeneca for the supply of  finished products from AstraZeneca at or prior to the formal closing of the transaction. According to information provided by AstraZeneca, sales of the products in the relevant territories for year end December 2017 amounted to approximately US$147.9 million.

Luye Pharma focuses on developing, producing, marketing and selling innovative pharmaceutical products in four of the largest and fastest growing therapeutic areas — oncology, cardiovascular, metabolism and the central nervous system, covering the main global pharmaceutical markets.  AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. Seroquel (quetiapine fumarate, immediate release, IR) and Seroquel XR (extended release formulation) are atypical anti-psychotic medicines with antidepressant properties. The main indications for Seroquel are the treatment of schizophrenia and bipolar disorder. Seroquel XR is also approved in some markets for major depressive disorder and generalised anxiety disorder. Luye Pharma believes that the acquisition of Seroquel and Seroquel XR will assist further expansion in the PRC and into markets outside of China.

KWM’s cross border-team was led by Beijing based partner Huang Jianwen (Corporate& MA), and partners Susan Ning (Anti-trust), Chen Wenping (IP), Lou Xianying (IP) and Zhang Ci (Tax) were key team members. The London team was led by Greg Stonefield (Corporate) and Barri Mendelsohn (Corporate) with other London team members comprising Joseph Newitt (Corporate), Anna Feros (IP), Sam Coleman (Tax), and David Wilman (Employment). 

Huang Jianwen commented that “We are honoured to have had the opportunity of participating in this landmark strategic transaction for Luye Pharma which we believe will contribute to Luye Pharma’s global development.  This transaction is a superb example that demonstrates not only our integrated approach to complex cross border transactions but also the depth and strength of our international resources to achieve a successful outcome for our clients.”

Greg Stonefield said, “We are delighted to support our China team and a key client of the firm on this important transaction, as our client seeks to expand its business offering and presence around the world.  We are ideally suited to advise China-based clients on their international transactions and international clients seeking to invest in China and we look forward to continuing to support Luye and others as this trend continues.”

Wang Rongkang, Managing Partner of KWM EUME, said “This is yet another example of our global team working together effectively to deliver results for our Chinese clients on key strategic transactions and initiatives.”

Luye Legal Team commented, “The King & Wood Mallesons legal team was irreplaceable in the whole transaction. We highly appreciate the assistance from King & Wood Mallesons’ legal team.” 

Media Contact

Share on LinkedIn Share on Facebook Share on Twitter Share on Google+
    You might also be interested in

    On 3 March 2019, King & Wood Mallesons (KWM) successfully held the inauguration ceremony to launch the KWM Belt & Road Center for International Cooperation and Facilitation (BRCICF) and the “Belt &...

    11 March 2019

    The office of the U.S. Trade Representative (the “USTR”) has granted 984.

    25 January 2019

    Qingdao Haier is the first Chinese public company to directly float its shares on Frankfurt Stock Exchange. It’s also the first Chinese public company to trade and raise capital on a European...

    24 October 2018

    Of the 30 KWM partners who were recognized as Leading Lawyers, 7 partners were named as “Market-Leading Lawyers” in their respective practice areas.

    29 September 2018
  • 陕西广播电视台影视频道招聘启事 2019-04-11
  • 人民网驻厦门记者报道集(无效) 2019-04-03
  • 发现食品安全问题拨打12331投诉 2019-03-26
  • 2018年04期 中国国家地理网 2019-03-19
  • 港台名人"坊" 2019-03-19
  • 孙杨、宁泽涛扛起中国游泳大旗 2019-03-10
  • 日本将成人年龄下调至18岁 女性结婚年龄上调至18岁 2019-03-10
  • 第九届海峡两岸文化创意产业展在台北开幕 2019-02-24
  • 多看看终极格斗比赛,你就知道什么是太急了 2019-02-24
  • 回复@老老保老张工:伪高工不仅智力低下,知识也很匮乏也!连啥叫计划经济都没搞懂! 2019-02-02
  • 第三届“五个一百”网络正能量评选活动 2019-02-02
  • 在粪坑里优胜的是蛆虫,在不公正的社会里优胜的是蛀虫。 2019-01-27
  • 犬伤人,有人伤人厉害吗 2018-07-14
  • 和顺“四个不放过”严查隐患 2018-07-13
  • 财政部:对原产于美国的500亿美元进口商品加征关税 2018-07-12
  • 319| 548| 763| 301| 120| 881| 777| 849| 345| 382|